Abstract
The kallikrein inhibitor-peptide content of Tityus serrulatus scorpion crude venom was purified by Sephadex G-50 and Sephadex G-25 fine gel filtration chromatographies, followed by two steps of reverse-phase column on HPLC. The isolated inhibitor peptide was homogeneous in its N-terminal and partial amino acid sequence, showing a molecular weight of 4.489 Da by mass spectrometry and amino acid analysis. The peptide was tested with rat plasma and urine kallikrein, which resulting in an inhibition with similar afinity to both enzymes, showing an IC50 of 14.3 μM after 13 and 8 min, respectively, using kininogen as substrate on the isolated guinea-pig ileum bioassay. The porcine pancreatic kallikrein showed after 10 min an IC50 value of 12.6 μM with H-D-Val-Leu-Arg-pNA HCl as substrate. In addition, the isolated peptide significantly inhibited porcine pancreatic kallikrein with values in the range of apparent or absolute calculated peptide K i = 2.5 μM. The inhibitor was heat resistant and stable at pH values less than 5.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Amaral, C. F. S., and Rezende, N. A. (1997). Both cardiogenic and non-cardiogenic factors are involved in the pathogenesis of pulmonary oedema after scorpion envenoming, Toxicon 35, 997–998.
Castania, A., and Rothschild, A. M. (1974). Lowering of kininogen in the rat blood by adrenaline and its inhibition by symphatolytic agents, heparin and aspirin, Br. J. Pharmacol. 50, 375–381.
Colman, R. W., and Wong, P. Y. (1979). Kallikrein--kinin system in pathologic conditions, In: Handbook of Experimental Pharmacology, Vol. XXV (Supplement): Bradykinin, Kallidin, and Kallikrein (Erdos, E. G., ed.), Springer, Berlin.
De Matos, M. I., Rocha, A. O., Leite, R., and Freire-Maia, L. (1997). Lung oedema induced by Tityus serrulatus scorpion venom in rat, Comp. Biochem. Physiol. 118C, 143–148.
Edman, P. (1950). Method for determination of amino acid sequence in peptides, Acta Chem. Scand. 10, 710–768.
Ferreira, L. A. F., Alves, E. W., and Henriques, O. B. (1993a). Peptide T, a novel bradykinin potentiator isolated from Tityus serrulatus scorpion venom, Toxicon 31, 941–947.
Ferreira, L. A. F., Bergamasco, M., and Henriques, O. B. (1993b). Crude venom from the scorpion Tityus serrulatus inhibits angiotensin-converting enzyme activity in the rat, J. Nat. Toxins 3, 145–153.
Ferreira, L. A. F., Bergamasco, M., and Henriques, O. B. (1994). Isolation and properties of a T-kininogenase from bovine erythrocyte membranes, J. Protein Chem. 13, 547–552.
Ferreira, L. A. F., Bergamasco, M., and Angnes, L. (1996). Measurement of bradykinin, protein, Na+, Cl−, K+ and Zn++ concentrations in rat urine after intraperitoneal injection of Tityus serrulatus venom, J. Venom Anim. Toxins 2, 156–161.
Freire-Maia, L., and Campos, J. A. (1987). Response to the Letter to the Editor by Gueron and Ovysyshcher on the treatment of the cardiovascular manifestations of the scorpion envenomation, Toxicon 25, 125–130.
Freire-Maia, L., and Campos, J. A. (1989). Pathophysiology and treatment of scorpion poisoning, In: Natural Toxins. Characterization, Pharmacology and Therapeutics (Ownby, C. L., and Odell, G. V., eds.), Pergamon Press, Oxford.
Freire-Maia, L., Pinto, G. I., and Franco, I. (1974). Mechanism of the cardiovascular effects produced by purified scorpion toxin in the rat, J. Pharm. Exp. Ther. 188, 207–213.
Freire-Maia, L., Almeida, H. O., Cunha-Mello, J. R., Azevedo, A. D., and Barroso, J. (1978). Mechanism of the pulmonary oedema induced by intravenous injection of scorpion toxin in the rat, Agents Actions 8, 113–118.
Friberger, P., Aurell, L., and Claeson, G. (1982). Chromogenic substrate of kallikrein and related enzymes, Agents Actions 9, 83–90.
Geiger, R., Stuckstedte, U., and Fritz, H. (1980). Isolation and characterization of human urinary kallikrein. Hoppe-Zeyler's Z. Physiol. Chem. 361, 1003–1016.
Hojima, Y., Isobe, M., and Moryia, H. (1977). Kallikrein inhibitor in rat plasma, J. Biochem. 81, 37–46.
Ismail, M., Fatani, J. Y., and Babees, T. T. (1992). Experimental treatment protocols for scorpion envenomation: A review of common therapies and an effect of kallikrein--kinin inhibitors, Toxicon 30, 1257–1279.
Laemlli, U. K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature 217, 680–685.
Lowry, O. H., Rosenbrough, N. J., Farr, A. L., and Randall, R. (1951). Protein measurement with folin reagent, Biol. Chem. 192, 265–275.
Oliva, M. L., Grisolia, D., Sampaio, M. V., and Sampaio, C. A. M. (1982). Properties of hightly purified human plasma kallikrein, Agents Actions Suppl. 9, 52–57.
Rothschild, A. M., and Castania, A. (1976). Contribution of vasopressor and kininogen changes towards acute adrenaline pulmonary edema in rat. Naunyn-Schmiedebergs Arch. Pharmacol. 295, 117–181.
Shimamoto, K., and Limura, O. (1992). The renal kallikrein--kinin system at the prehypertensive stage of hypertension, Agents Actions Suppl. 38, 287–293.
Vogel, R. (1979). Kallikrein inhibitors, In: Handbook of Experimental Pharmacology, Vol. XXV (Supplement): Bradykinin, Kallidin, and Kallikrein (Erdos, E. G., ed.), Springer, Berlin, pp. 163–225.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ferreira, L.A.F., Zingalli, R., Habermehl, G. et al. Isolation and Properties of a New Kallikrein Inhibitor from Tityus serrulatus Venom. J Protein Chem 17, 799–805 (1998). https://doi.org/10.1023/A:1020778302161
Published:
Issue Date:
DOI: https://doi.org/10.1023/A:1020778302161